Shockingly, many layoff trackers exist in the pharma world. Each paints the same picture: patent cliffs and turbulent market conditions have led to pharma budget cuts, which means staff cuts. Novartis, Merck KGaA, Amgen, Sanofi, GSK, Bristol Myers Squibb and Takeda are just a handful of the hundreds of businesses making budget cuts in pharma. But does this mean we must pull the handbrake on innovation?
Read More..
The Regulatory Paradox: Vibe Coding Medical Tools in a Compliance-Heavy Industry
Healthcare innovation is now at a crossroads, where the pursuit to make revolutionary strides forward is matched only by the challenge of making tools that actually help the people who pick them up and use them.
Write a comment ...